Synthesis and Study of Anti Parkinsonism activity of 8-azabicyclo [3.2.1] octane Analogs
Saurav M. Verma

Pharmacol. Pharm. Vol.2 No.2, March 31, 2011
DOI:10.4236/pp.2011.22012

Genetic Polymorphisms of CYP2C9: Comparison of Prevalence in the Lebanese Population with Other Populations
Yolande B. Saab, Taimour Langaee

Pharmacol. Pharm. Vol.2 No.2, March 30, 2011
DOI:10.4236/pp.2011.22011

Symptoms and Their Interpretation in Patients Self-Treating Abdominal Cramping and Pain with a Spasmolytic (Butylscopolamine Bromide)—A Pharmacy-Based Survey
Stefan Müller-Lissner, Eckhard Schäfer, Anke Kondla

Pharmacol. Pharm. Vol.2 No.2, March 30, 2011
DOI:10.4236/pp.2011.22010

Corticosteroids and ICU Course of Community Acquired Pneumonia in Egyptian Settings
Nirmeen A. Sabry, Emad El-Din Omar

Pharmacol. Pharm. Vol.2 No.2, March 30, 2011
DOI:10.4236/pp.2011.22009

Studies on the in Vitro Dissolution of Insoluble Volatile Drug from Su-Anxin Nasal Inhalant and Its Correlation on the Nose Steady Self-Controllable Expiration and Inspiration at Night
Xiaodong Li, Guoxiang Xie, Suyun Li, Chao Hou

Pharmacol. Pharm. Vol.2 No.2, March 30, 2011
DOI:10.4236/pp.2011.22008